Financial News

Morgan Stanley Upgrades Loxo On The Potential Of A Targeted Cancer Therapy

By: via Benzinga
Loxo Oncology Inc (NASDAQ: LOXO) holds an opportunity to differentiate itself among RET inhibitors while developing medicines for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Feedback